ARTICLE | Top Story
Scios reports Natrecor results
November 15, 2000 8:00 AM UTC
SCIO said data from the 498-patient Phase III Vasodilation in the Management of Acute CHF (VMAC) study showed that its Natrecor B-type natriuretic peptide improved hemodynamic measures and alleviated ...